FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 162 filers reported holding FIBROGEN INC in Q1 2022. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $93,107 | -79.3% | 107,900 | -35.3% | 0.00% | -100.0% |
Q2 2023 | $450,449 | -84.8% | 166,833 | +5.3% | 0.00% | -80.0% |
Q1 2023 | $2,956,994 | +26.9% | 158,467 | +9.0% | 0.01% | 0.0% |
Q4 2022 | $2,329,532 | +39.9% | 145,414 | +13.6% | 0.01% | +25.0% |
Q3 2022 | $1,665,000 | +23.2% | 127,973 | 0.0% | 0.00% | +33.3% |
Q2 2022 | $1,351,000 | -12.3% | 127,973 | -0.1% | 0.00% | 0.0% |
Q1 2022 | $1,540,000 | -11.0% | 128,158 | +4.5% | 0.00% | 0.0% |
Q4 2021 | $1,730,000 | +38.0% | 122,676 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $1,254,000 | -69.3% | 122,676 | -20.5% | 0.00% | -66.7% |
Q2 2021 | $4,091,000 | -43.6% | 154,335 | -26.1% | 0.01% | -50.0% |
Q1 2021 | $7,253,000 | -16.9% | 208,958 | -11.2% | 0.02% | -21.7% |
Q4 2020 | $8,727,000 | +10.8% | 235,282 | +22.8% | 0.02% | 0.0% |
Q3 2020 | $7,877,000 | -5.9% | 191,551 | -7.2% | 0.02% | -11.5% |
Q2 2020 | $8,370,000 | +337.1% | 206,520 | +274.7% | 0.03% | +271.4% |
Q1 2020 | $1,915,000 | +27.0% | 55,113 | +56.8% | 0.01% | +75.0% |
Q4 2019 | $1,508,000 | +35.0% | 35,149 | +16.3% | 0.00% | +33.3% |
Q3 2019 | $1,117,000 | -23.1% | 30,216 | -6.0% | 0.00% | -40.0% |
Q2 2019 | $1,452,000 | +7.5% | 32,131 | +29.2% | 0.01% | 0.0% |
Q1 2019 | $1,351,000 | -27.4% | 24,860 | -18.8% | 0.01% | -28.6% |
Q4 2018 | $1,861,000 | 0.0% | 30,626 | 0.0% | 0.01% | 0.0% |
Q3 2018 | $1,861,000 | +7.1% | 30,626 | +10.3% | 0.01% | +16.7% |
Q2 2018 | $1,738,000 | +30.1% | 27,767 | -4.0% | 0.01% | +20.0% |
Q1 2018 | $1,336,000 | -6.0% | 28,918 | -3.5% | 0.01% | 0.0% |
Q4 2017 | $1,421,000 | -29.2% | 29,982 | -19.6% | 0.01% | -28.6% |
Q3 2017 | $2,007,000 | +96.2% | 37,306 | +17.7% | 0.01% | +75.0% |
Q2 2017 | $1,023,000 | +31.0% | 31,691 | 0.0% | 0.00% | +33.3% |
Q1 2017 | $781,000 | +36.1% | 31,691 | +18.2% | 0.00% | 0.0% |
Q4 2016 | $574,000 | +72.4% | 26,812 | +66.8% | 0.00% | +50.0% |
Q3 2016 | $333,000 | +80.0% | 16,077 | +42.6% | 0.00% | +100.0% |
Q2 2016 | $185,000 | -22.9% | 11,272 | +0.1% | 0.00% | 0.0% |
Q1 2016 | $240,000 | -26.6% | 11,264 | +4.9% | 0.00% | -50.0% |
Q4 2015 | $327,000 | -39.7% | 10,742 | -56.5% | 0.00% | -60.0% |
Q3 2015 | $542,000 | – | 24,720 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vantage Consulting Group Inc | 605,713 | $9,703,522 | 5.73% |
ARMISTICE CAPITAL, LLC | 3,864,000 | $61,901,280 | 1.08% |
Logos Global Management LP | 525,000 | $8,410,500 | 0.98% |
5AM Venture Management, LLC | 225,583 | $3,613,840 | 0.97% |
Intercontinental Wealth Advisors, LLC | 191,300 | $3,064,626 | 0.91% |
BHK Investment Advisors, LLC | 87,550 | $1,402,551 | 0.79% |
Integral Health Asset Management, LLC | 175,000 | $2,803,500 | 0.59% |
Nan Fung Group Holdings Ltd | 34,106 | $546,378 | 0.38% |
Soleus Capital Management, L.P. | 113,463 | $1,817,677 | 0.26% |
Point72 Asset Management, L.P. | 4,781,645 | $76,601,953 | 0.26% |